| Science, Research, and Medicine | Lifetime | 2 | BY 1 | 98.75 |
| Biotechnology and Related Fields | Lifetime | 5 | BY 1 | 99.10 |
| Biomedical and Engineering Education | Lifetime | 16 | BY 1 | 98.11 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 253 | BY 1 | 99.01 |
| Long-Term Effects of COVID-19 | Lifetime | 189 | BY 1 | 98.17 |
| COVID-19 Clinical Research Studies | Lifetime | 355 | BY 1 | 98.49 |
| Health and Medical Research Impacts | Lifetime | 61 | BY 1 | 97.81 |
| Innovation and Socioeconomic Development | Lifetime | 58 | BY 1 | 98.83 |
| Biomedical Ethics and Regulation | Lifetime | 50 | BY 1 | 97.60 |
| Genetics, Bioinformatics, and Biomedical Research | Lifetime | 68 | BY 1 | 97.09 |
| CRISPR and Genetic Engineering | Lifetime | 536 | BY 1 | 98.18 |
| COVID-19 epidemiological studies | Lifetime | 446 | BY 1 | 96.93 |
| Vaccine Coverage and Hesitancy | Lifetime | 457 | BY 1 | 97.02 |
| COVID-19 and healthcare impacts | Lifetime | 679 | BY 1 | 93.47 |
| Pharmaceutical Economics and Policy | Lifetime | 303 | BY 1 | 96.10 |
| Biosimilars and Bioanalytical Methods | Lifetime | 264 | BY 1 | 95.58 |
| Animal Genetics and Reproduction | Lifetime | 644 | BY 1 | 96.15 |
| Advances in Oncology and Radiotherapy | Lifetime | 314 | BY 1 | 94.16 |
| Bioeconomy and Sustainability Development | Lifetime | 119 | BY 1 | 91.62 |
| Genetically Modified Organisms Research | Lifetime | 459 | BY 1 | 90.39 |
| Ethics in Clinical Research | Lifetime | 960 | BY 1 | 89.51 |
| Immune responses and vaccinations | Lifetime | 903 | BY 1 | 80.85 |
| Social Media in Health Education | Lifetime | 912 | BY 1 | 81.12 |
| Healthcare Systems and Challenges | Lifetime | 551 | BY 1 | 71.51 |
| Sex and Gender in Healthcare | Lifetime | 790 | BY 1 | 71.72 |
| Conferences and Exhibitions Management | Lifetime | 481 | BY 1 | 58.73 |
| Academic Publishing and Open Access | Lifetime | 875 | BY 2 | 46.10 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 252 | BY 1 | 98.88 |
| Long-Term Effects of COVID-19 | 2021-2025 | 193 | BY 1 | 97.69 |
| Biotechnology and Related Fields | 2021-2025 | 2 | BY 1 | 98.24 |
| CRISPR and Genetic Engineering | 2021-2025 | 130 | BY 1 | 96.69 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 147 | BY 1 | 97.30 |
| COVID-19 Clinical Research Studies | 2021-2025 | 591 | BY 1 | 97.40 |
| COVID-19 epidemiological studies | 2021-2025 | 293 | BY 1 | 96.11 |
| CAR-T cell therapy research | 2021-2025 | 658 | BY 1 | 96.17 |
| Science, Research, and Medicine | 2021-2025 | 7 | BY 1 | 95.19 |
| Biomedical Ethics and Regulation | 2021-2025 | 82 | BY 1 | 89.67 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 677 | BY 1 | 90.65 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 248 | BY 1 | 86.09 |
| vaccines and immunoinformatics approaches | 2021-2025 | 549 | BY 1 | 81.02 |
| Innovation and Socioeconomic Development | 2021-2025 | 372 | BY 1 | 83.44 |
| Health and Medical Research Impacts | 2021-2025 | 396 | BY 1 | 75.70 |
| Immune responses and vaccinations | 2021-2025 | 521 | BY 1 | 67.66 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 438 | BY 1 | 65.95 |
| Spaceflight effects on biology | 2021-2025 | 934 | BY 1 | 63.27 |
| Biomedical and Engineering Education | 2021-2025 | 725 | BY 1 | 59.59 |
| Neuroethics, Human Enhancement, Biomedical Innovations | 2021-2025 | 368 | BY 1 | 46.93 |
